Indian Cinema Hits Record ₹6,398 Crore Revenue in First Half of 2026

The ₹650-crore-plus increase over H1 2025 is the headline number, but the more useful signal for exhibitors is that admissions also moved: footfalls rose 5% to 37.8 crore.

This is not simply a ticket-price story. After three years of flat or declining admissions, cinemas have brought back incremental traffic. For distributors and producers, that improves the yield case for a theatrical window—provided a title can break through an increasingly concentrated market.

₹6,398 crore is a record, but revenue is narrowing

The first half is the highest-grossing post-pandemic H1 for the Indian exhibition business. Four of the six months cleared ₹1,000 crore, while June alone generated ₹1,038 crore, including projected collections from films still in theatres.

Yet the revenue mix is becoming more top-heavy. The top 15 films delivered 58% of domestic box office in the period, against 49% a year earlier. Six films crossed ₹200 crore, up from four in H1 2025. At the ₹100-crore level, however, the count fell from 17 to 13.

That split matters. The market is producing more outsized winners, but fewer mid-level grossers. A saturation release with major star value, marketing weight and strong territory rights has a clearer path to scale. For the rest of the slate, cinema footfalls alone do not guarantee ROI.

One film took almost a fifth of the market

Dhurandhar: The Revenge was the largest individual contributor, accounting for nearly 20% of India’s total H1 box office, according to the report cited by Fortune India. That is a sizeable concentration risk for a six-month market.

The pattern changes how headline collection figures should be read. A 10% rise in total gross does not imply an even improvement across producers, distributors or screens. The key operating metric is now the gap between event-film performance and the broader release pipeline.

For exhibitors, the upside is higher footfalls and more ₹1,000-crore months. The downside is dependence on a short run of marquee titles to fill seats. For studios, the pressure is on opening-weekend conversion and release-date positioning rather than on a long tail of moderate performers.

Hindi gains share; 2026 record depends on H2 delivery

Hindi cinema expanded its domestic box-office share to 44% in H1 2026 from 39% a year earlier. Tamil cinema moved in the other direction, falling to 12% from 17%. Marathi cinema reached a 4% share, its highest post-pandemic level.

The annual run-rate is substantial. January–June has contributed roughly 42% of yearly domestic collections over the past three years. If that ratio holds, the market could cross ₹15,000 crore in 2026, above the current annual record of ₹13,395 crore set in 2025. Ormax Media’s report also points to a potential 100-crore admissions year, compared with the post-pandemic high of 94.3 crore footfalls in 2023.

The second-half calendar includes Ramayana: Part 1, King, Toxic, Fauzi, Jailer 2, Avengers: Doomsday, Spider-Man: Brand New Day and The Odyssey. The financial verdict is straightforward: H1 has established the highest post-pandemic base, but a ₹15,000-crore year requires those tentpoles to convert interest into sustained theatre traffic—not merely large openings.